![Spilled Talc Powder J&j Story Update Adobe Stock 804366889](https://img.cosmeticsandtoiletries.com/files/base/allured/all/image/2024/06/spilled_talc_powder_J_J_story_updateAdobeStock_804366889.6674aa167c683.png?auto=format%2Ccompress&q=70&rect=34%2C10%2C2166%2C1221&w=700)
Image by Mohammed at Adobe Stock
In May, Johnson & Johnson (J&J) offered $6.48 billion to resolve more than 99% of ovarian cancer claims. Last week, we reported J&J settled for $700 million with 42 states and Washington, D.C., that were investigating the company's alleged "misleading" marketing. Now the company faces a new class action seeking damages and medical monitoring, as well as evidence from a recent study "supporting a positive association" between intimate care products including genital talc with ovarian cancer.